---
title: 'Clinical Practice Recommendations for Hematopoietic Cell Transplantation and
  Cellular Therapies in Follicular Lymphoma: A Collaborative Effort on behalf of The
  American Society of Transplantation and Cellular Therapy and the European Society
  of Blood and Marrow Transplantation'
date: '2024-07-07'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38972511/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20240708182534&v=2.18.0.post9+e462414
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: Follicular lymphoma (FL) is the most common indolent B-cell non-Hodgkin
  lymphoma (NHL), accounting for nearly one-third of all NHL. The therapeutic landscape
  for patients with FL has significantly expanded over the past decade, but the disease
  continues to be considered incurable. Hematopoietic cell transplantation (HCT) is
  potentially curative in some cases. Recently, the emergence of chimeric antigen
  receptor T-cell therapy (CAR-T) for patients with relapsed/refractory (R/R) FL has
  ...
disable_comments: true
---
Follicular lymphoma (FL) is the most common indolent B-cell non-Hodgkin lymphoma (NHL), accounting for nearly one-third of all NHL. The therapeutic landscape for patients with FL has significantly expanded over the past decade, but the disease continues to be considered incurable. Hematopoietic cell transplantation (HCT) is potentially curative in some cases. Recently, the emergence of chimeric antigen receptor T-cell therapy (CAR-T) for patients with relapsed/refractory (R/R) FL has ...